tykhr
sign in
free sign up
Kazia Therapeutics Ltd ADR
Biotechnology
Healthcare
KZIA
575 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.51
52 week high
12.40
high
7.77
52 week low
0.00
low
7.37
growth
133.23 %
previous Close
7.52
P/E ratio
-1
market cap
9.18 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-12.30 %
60.60 %
eps surprise
0.00 %
net profit margin
0.00 %
723.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top